Catalyst calendar
Data as of 2026-08-19 16:00 UTC · tracked universe polled every 15 minutes
Three kinds of date: a PDUFA date (the deadline the FDA sets itself to decide on a drug application), an AdCom (an FDA advisory-committee meeting that reviews it in public), and a readout window (when a trial's results are expected). Dates marked confirmed by the company come from an 8-K or press-release quote; our estimate is a rule-derived window off the trial's registered primary-completion date (see methodology) — never shown the same way. Today: 200 estimated readout windows and 0 disclosed PDUFA/AdCom dates.
Next 7 days
| Date | Ticker | Phase | Event |
|---|---|---|---|
| 2027-06-21 in 44w | $ITCI | Phase 3 | Multicenter Study of Lumateperone for the Treatment of Irritability Associated… NCT06706674 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism… NCT03969329 |
| 2027-06-30 in 45w | $VRTX | Phase 3 | A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type… NCT04786262 |
| 2027-06-30 in 45w | $AMGN | Phase 3 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab… NCT05920356 |
| 2027-07-01 in 45w | $VKTX | Phase 3 | VK2735 for Weight Management Phase 3 NCT07104500 |
| 2027-07-01 in 45w | $VKTX | Phase 3 | VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2) NCT07104383 |
| 2027-07-05 in 46w | $AMGN | Phase 3 | Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line… NCT06211036 |
| 2027-08-07 in 50w | $BIIB | Phase 3 | A Study of BIIB067 (Tofersen) Initiated in Clinically Presymptomatic Adults… NCT04856982 |
| 2027-09-24 in 57w | $BIIB | Phase 3 | A Study to Learn About the Effect of Higher Doses of Nusinersen (BIIB058) Given… NCT05067790 |
| 2027-09-30 in 58w | $VRTX | Phase 3 | Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis… NCT06460506 |
| 2027-10-07 in 59w | $ARGX | Phase 3 | A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP NCT07091630 |
| 2027-11-14 in 65w | $VRTX | Phase 3 | Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With… NCT05356195 |
| 2027-11-16 in 65w | $BIIB | Phase 3 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone… NCT06953583 |
| 2027-12-27 in 71w | $ALNY | Phase 3 | TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in… NCT07223203 |
| 2027-12-31 in 71w | $PTCT | Phase 3 | A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With… NCT05515536 |
| 2028-03-01 in 80w | $IOVA | Phase 3 | Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With… NCT05727904 |
| 2028-03-31 in 84w | $ALNY | Phase 3 | A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With… NCT06679946 |
| 2028-06-23 in 96w | $BIIB | Phase 3 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its… NCT07444476 |
| 2028-06-30 in 97w | $AXSM | Phase 3 | A Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With… NCT07717892 |
| 2028-06-30 in 97w | $AXSM | Phase 3 | A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD NCT07717879 |
| 2028-09-18 in 109w | $ZEAL | Phase 3 | Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel… NCT07228403 |
| 2028-10-23 in 114w | $ZEAL | Phase 3 | Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS NCT07197944 |